Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Clinical trial NCT03802955 · COMPLETED
Trial details
- NCT number
- NCT03802955
- Sponsor
- Adagene (Suzhou) Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2021-11-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.